2-[2-(2α-メチルピロリジノ)エチル]-5-(4-シアノフェニル)ベンゾフラン2-[2-[(2R)-2α-メチルピロリジノ]エチル]-5-(4-シアノフェニル)ベンゾフラン4-[2-[2-[(2R)-2-メチル-1-ピロリジニル]エチル]ベンゾフラン-5-イル]ベンゾニトリル4-(2-{2-[(2R)-2-メチルピロリジン-1-イル]エチル}-1-ベンゾフラン-5-イル)ベンゾニトリルABT-239 (ABT239ABT-239, 10 mM in DMSO(R)-4-[2-[2-(2-Methylpyrrolidinyl)ethyl]benzofuran-5-yl]benzonitrile(R)-4-(2-(2-(2-Methylpyrrolidin-1-yl)- ethyl)benzofuran-5-yl)benzonitril4-(2-{2-[(2R)-2-Methyl-1-pyrrolidinyl]ethyl}-1-benzofuran-5-yl)benzonitrile
MeSH Pharmacological ClassificationDrugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.